213 related articles for article (PubMed ID: 29235475)
1. Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase.
Reckel S; Gehin C; Tardivon D; Georgeon S; Kükenshöner T; Löhr F; Koide A; Buchner L; Panjkovich A; Reynaud A; Pinho S; Gerig B; Svergun D; Pojer F; Güntert P; Dötsch V; Koide S; Gavin AC; Hantschel O
Nat Commun; 2017 Dec; 8(1):2101. PubMed ID: 29235475
[TBL] [Abstract][Full Text] [Related]
2. Pleckstrin homology domain of p210 BCR-ABL interacts with cardiolipin to regulate its mitochondrial translocation and subsequent mitophagy.
Shimasaki K; Watanabe-Takahashi M; Umeda M; Funamoto S; Saito Y; Noguchi N; Kumagai K; Hanada K; Tsukahara F; Maru Y; Shibata N; Naito M; Nishikawa K
Genes Cells; 2018 Jan; 23(1):22-34. PubMed ID: 29205725
[TBL] [Abstract][Full Text] [Related]
3. The Dbl homology domain of BCR is not a simple spacer in P210BCR-ABL of the Philadelphia chromosome.
Kin Y; Li G; Shibuya M; Maru Y
J Biol Chem; 2001 Oct; 276(42):39462-8. PubMed ID: 11502748
[TBL] [Abstract][Full Text] [Related]
4. Invadopodia and rolling-type motility are specific features of highly invasive p190(bcr-abl) leukemic cells.
Daubon T; Rochelle T; Bourmeyster N; Génot E
Eur J Cell Biol; 2012; 91(11-12):978-87. PubMed ID: 22717125
[TBL] [Abstract][Full Text] [Related]
5. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA
J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280
[TBL] [Abstract][Full Text] [Related]
6. The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase.
Roumiantsev S; de Aos IE; Varticovski L; Ilaria RL; Van Etten RA
Blood; 2001 Jan; 97(1):4-13. PubMed ID: 11133737
[TBL] [Abstract][Full Text] [Related]
7. Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics.
Reckel S; Hamelin R; Georgeon S; Armand F; Jolliet Q; Chiappe D; Moniatte M; Hantschel O
Leukemia; 2017 Jul; 31(7):1502-1512. PubMed ID: 28111465
[TBL] [Abstract][Full Text] [Related]
8. Novel role of pleckstrin homology domain of the Bcr-Abl protein: analysis of protein-protein and protein-lipid interactions.
Miroshnychenko D; Dubrovska A; Maliuta S; Telegeev G; Aspenström P
Exp Cell Res; 2010 Feb; 316(4):530-42. PubMed ID: 19944685
[TBL] [Abstract][Full Text] [Related]
9. The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation.
Sahay S; Pannucci NL; Mahon GM; Rodriguez PL; Megjugorac NJ; Kostenko EV; Ozer HL; Whitehead IP
Oncogene; 2008 Mar; 27(14):2064-71. PubMed ID: 17922031
[TBL] [Abstract][Full Text] [Related]
10. Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl.
Harnois T; Constantin B; Rioux A; Grenioux E; Kitzis A; Bourmeyster N
Oncogene; 2003 Sep; 22(41):6445-54. PubMed ID: 14508524
[TBL] [Abstract][Full Text] [Related]
11. p38 MAPK-mediated activation of NF-kappaB by the RhoGEF domain of Bcr.
Korus M; Mahon GM; Cheng L; Whitehead IP
Oncogene; 2002 Jul; 21(30):4601-12. PubMed ID: 12096337
[TBL] [Abstract][Full Text] [Related]
12. Contributions of the RhoGEF activity of p210 BCR/ABL to disease progression.
Tala I; Chen R; Hu T; Fitzpatrick ER; Williams DA; Whitehead IP
Leukemia; 2013 Apr; 27(5):1080-9. PubMed ID: 23207522
[TBL] [Abstract][Full Text] [Related]
13. Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein.
McWhirter JR; Wang JY
Oncogene; 1997 Oct; 15(14):1625-34. PubMed ID: 9349495
[TBL] [Abstract][Full Text] [Related]
14. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
van Rhee F; Hochhaus A; Lin F; Melo JV; Goldman JM; Cross NC
Blood; 1996 Jun; 87(12):5213-7. PubMed ID: 8652835
[TBL] [Abstract][Full Text] [Related]
15. Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24 homology domains but not the pleckstrin homology one.
Martinelli G; Amabile M; Giannini B; Terragna C; Ottaviani E; Soverini S; Saglio G; Rosti G; Baccarani M
Haematologica; 2002 Jul; 87(7):688-94; discussion 694. PubMed ID: 12091118
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of GEF activity of Bcr protein DH domain].
Miroshnychenko DO; Teleheiev HD; Maliuta SS
Ukr Biokhim Zh (1999); 2007; 79(5):116-21. PubMed ID: 18357784
[TBL] [Abstract][Full Text] [Related]
17. Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.
Adnan-Awad S; Kim D; Hohtari H; Javarappa KK; Brandstoetter T; Mayer I; Potdar S; Heckman CA; Kytölä S; Porkka K; Doma E; Sexl V; Kankainen M; Mustjoki S
Leukemia; 2021 Jul; 35(7):1964-1975. PubMed ID: 33168949
[TBL] [Abstract][Full Text] [Related]
18. Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs.
Daubon T; Chasseriau J; El Ali A; Rivet J; Kitzis A; Constantin B; Bourmeyster N
Oncogene; 2008 Apr; 27(19):2673-85. PubMed ID: 18059343
[TBL] [Abstract][Full Text] [Related]
19. PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl.
Jain SK; Susa M; Keeler ML; Carlesso N; Druker B; Varticovski L
Blood; 1996 Sep; 88(5):1542-50. PubMed ID: 8781408
[TBL] [Abstract][Full Text] [Related]
20. BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML).
Arana-Trejo RM; Ruíz Sánchez E; Ignacio-Ibarra G; Báez de la Fuente E; Garces O; Gómez Morales E; Castro Granados M; Ovilla Martínez R; Rubio-Borja ME; Solís Anaya L; Herrera P; Delgado Llamas J; Kofman S
Clin Lab Haematol; 2002 Jun; 24(3):145-50. PubMed ID: 12067277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
